Notice Number: NOT-CA-18-082
Key Dates
Release Date: June 26, 2018
PAR-16-139
NOT-CA-18-081
Issued by
National Cancer Institute (NCI)
Purpose
The purpose of this notice is to inform interested applicants that the expiration date and Application and Submission Information for the Funding Opportunity Announcement (FOA) PAR-16-139 Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25)" have been changed.
Part 1. Overview Information
Key Dates
Currently reads:
Expiration Date
September 8, 2018
Modified to read:
Expiration Date
January 8, 2019
Part 2. Full Text of Announcement
Section IV. Application and Submission Information
Currently reads
Planned Enrollment Report
When conducting clinical research, follow all instructions for completing Planned Enrollment Reports as described in the SF424 (R&R) Application Guide.
PHS 398 Cumulative Inclusion Enrollment Report
When conducting clinical research, follow all instructions for completing Cumulative Inclusion Enrollment Report as described in the SF424 (R&R) Application Guide.
Modified to read
PHS Human Subjects and Clinical Trials Information
Form only available in FORMS-E application packages for use with due dates on or after January 25, 2018.
When involving NIH-defined human subjects research, clinical research, and/or clinical trials follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions:
If you answered "Yes" to the question "Are Human Subjects Involved?" on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or a Delayed Onset Study record.
Study Record: PHS Human Subjects and Clinical Trials Information
All instructions in the SF424 (R&R) Application Guide must be followed.
Delayed Onset Study: All instructions in the SF424 (R&R) Application Guide must be followed.
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Behrous Davani, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6098
Email: behrous.davani@nih.gov
and Human Services (HHS)
